Danaher Corporation $DHR Shares Purchased by Kestra Advisory Services LLC

Kestra Advisory Services LLC lifted its stake in shares of Danaher Corporation (NYSE:DHR – Free Report) by 4.9% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 78,390 shares of the conglomerate’s stock after buying an additional 3,643 shares during the period. Kestra Advisory Services LLC’s holdings in Danaher were worth $17,367,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the stock. Claro Advisors Inc. purchased a new stake in shares of Danaher in the 3rd quarter worth about $301,000. Quadcap Wealth Management LLC grew its holdings in Danaher by 7.8% in the third quarter. Quadcap Wealth Management LLC now owns 1,211 shares of the conglomerate’s stock worth $268,000 after purchasing an additional 88 shares during the period. Commonwealth Equity Services LLC increased its stake in shares of Danaher by 3.7% during the third quarter. Commonwealth Equity Services LLC now owns 88,507 shares of the conglomerate’s stock valued at $19,609,000 after purchasing an additional 3,119 shares in the last quarter. Collaborative Fund Advisors LLC bought a new position in shares of Danaher during the third quarter valued at approximately $548,000. Finally, Chicago Partners Investment Group LLC increased its stake in shares of Danaher by 12.3% during the third quarter. Chicago Partners Investment Group LLC now owns 14,943 shares of the conglomerate’s stock valued at $3,444,000 after purchasing an additional 1,637 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have recently commented on DHR. The Goldman Sachs Group reissued a “buy” rating and issued a $275.00 price target on shares of Danaher in a research report on Thursday, October 22nd. Robert W. Baird raised their price objective on Danaher from $246.00 to $254.00 and gave the company an “outperform” rating in a research report on Thursday, October 22nd. Citigroup lifted their price objective on Danaher from $230.00 to $270.00 and gave the company a “buy” rating in a research note on Thursday, October 22nd. Barclays boosted their target price on Danaher from $255.00 to $260.00 and gave the stock an “overweight” rating in a report on Thursday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. Eighteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average price target of $242.91.

Read Our Latest Analysis on DHR

Danaher Stock Performance

Shares of DHR stock opened at $230.34 on Monday. The company has a quick ratio of 1.29, a current ratio of 1.63 and a debt-to-equity ratio of 0.45. The company has a 50 day moving average price of $220.27 and a 200-day moving average price of $201.60. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The firm has a market capitalization of $162.05 billion, a PE ratio of 37.70, a P/E/G ratio of 2.89 and a beta of 0.76.

Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company had revenue of $6.55 billion for the quarter, compared to the consensus estimate of $6.56 billion. During the same quarter in the prior year, the firm earned $1.89 earnings per share. The firm’s revenue for the quarter was up 8.3% compared to the same quarter last year. As a group, equities research analysts expect that Danaher Corporation will post 8.59 earnings per share for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were paid a dividend of $0.40 per share. The ex-dividend date was Wednesday, September 30th. This represents a $1.60 dividend on an annualized basis and a yield of 0.7%. Danaher’s payout ratio is currently 26.19%.

Insider Buying and Selling at Danaher

In other news, CAO Christopher Bouda sold 7,598 shares of the stock in a transaction on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the transaction, the chief accounting officer directly owned 9,107 shares of the company’s stock, valued at $2,136,137.92. This represents a 45.48% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 10.80% of the stock is owned by insiders.

Danaher Company Profile

(Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing.

The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.